Skip to content

Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand

Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00800904
Enrollment
1210
Registered
2008-12-02
Start date
2009-05-31
Completion date
2009-11-30
Last updated
2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Inhaled corticosteroid, Thai patient eligibility, Persistent asthma

Brief summary

The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Established persistent asthma * Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer

Exclusion criteria

* Currently participating or have participated in a study with an investigational compound within the last 30 days * Current diagnosis of chronic obstructive pulmonary disease (COPD) * Smoked more than 10 packs a year

Design outcomes

Primary

MeasureTime frame
Asthma control testOn the survey date

Secondary

MeasureTime frame
Asthma control in mild, moderate and severe persistent asthma patientsOn the survey date

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026